Hyperhidrosis is characterized by excessive and unpredictable sweating. It can result in significant psychological and emotional social burden—especially when affecting the upper extremities and hands. This accounts for it being labeled as the “silent handicap.”
Hyperhidrosis is caused by overactivity of the central nervous system. Unfortunately, prescription medications, topical agents and Botox injections have not been shown to provide long-term relief. Endoscopic thoracic sympathectomy (ETS) surgery, however, has shown to provide lasting relief.
ETS partially removes the sympathetic nerve. This disrupts the flow of excessive sweating in the upper extremities and the hands. It has shown to provide relief of symptoms in majority of patients. However, it is also associated with the devastating complication of compensatory hyperhidrosis (excessive sweating in other parts of the body) in up to 80% of patients.
Selective ETS Surgery
Dr. Gharagozloo has pioneered the use of highly precise medical robotics for ETS surgery. Using minimally invasive, robotic-assisted systems provides the advantage of high-definition, magnified 3-D visualization. They are also minimally invasive and offer superior instrument maneuverability in confined spaces within the body.
This enables the surgeon to selectively cut the sympathetic nerves that go to the upper extremities. By better preserving the nerves that go to the other parts of the body, compensatory hyperhidrosis is lessened. Robotic-assisted selective endoscopic thoracic sympathectomy has been shown to relieve symptoms in 96% of patients—with compensatory sweating in only 7% of patients.
To learn more or to schedule a consultation with our Oncology and Thoracic Surgery Program clinical care coordinator, call (407) 303-4877.